search
Back to results

MS Spinal Mobilisation Study

Primary Purpose

Multiple Sclerosis

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Spinal Mobilisation Intervention
General Massage
Sponsored by
Edinburgh Napier University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis focused on measuring multiple sclerosis, myometer, muscle stiffness, spinal mobilisations, body sway, fatigue

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Must have Multiple Sclerosis diagnosis.
  • Must be able to walk independently.
  • Must have an EDSS score of 6 or below.

Exclusion Criteria:

Respond positively to any absolute contraindications for spinal manual therapy including:

  • segment instability
  • infectious disease
  • osteomyelitis
  • bone tumours
  • severe haemophilia
  • spinal cord damage
  • cervical arterial dysfunction

Respond positively to any relative contraindications for spinal manual therapy including:

  • spinal disc prolapse
  • spondylosis
  • inflammatory arthritides
  • osteoporosis
  • hypermobile syndrome
  • pregnancy
  • pregnancy
  • cancer
  • cardiovascular disease
  • respiratory disease
  • healing injury
  • adverse reaction to previous spinal treatment.

Sites / Locations

  • Edinburgh Napier University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental A - Mobilisation Intervention

Experimental B - General Massage

Arm Description

Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention.

Participants receive 4 separate treatment sessions of the 30 minute general massage.

Outcomes

Primary Outcome Measures

Participant Muscle Stiffness Measure
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Participant Muscle Stiffness Measure
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Participant Muscle Stiffness Measure
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Participant Muscle Stiffness Measure
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Participant Muscle Stiffness Measure
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Participant Single Leg Stance Body Sway Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Path Length
Force plate recording from single leg stance balance test.
Participant Sit-to-Stand Velocity
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Velocity
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Velocity
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Velocity
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Velocity
Force plate recording from sit-to-stand test.
Participant Pain Score - Visual Analogue Scale (VAS)
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Pain Score - Visual Analogue Scale (VAS)
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Pain Score - Visual Analogue Scale (VAS)
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Pain Score - Visual Analogue Scale (VAS)
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Pain Score - Visual Analogue Scale (VAS)
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.
Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.
Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.
Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.

Secondary Outcome Measures

Participant Muscle Tone Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Tone Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Tone Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Tone Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Tone Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Elasticity Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Elasticity Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Elasticity Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Elasticity Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Muscle Elasticity Measure
Myometer measured tone taken from Erector Spinae muscle central belly.
Participant Height
Measure taken in meters using a stadiometer.
Participant Mass
Measure taken in kilograms using digital electronic scales by the participant stepping on the scales.
Participant BMI
Calculated using height and mass.
Participant Age
Self-reported by participant using pre-screening online survey.
Participant Expanded Disability Status Scale (EDSS)
Self-reported by participant using pre-screening online survey based on disabilities associated with multiple sclerosis. Scale ranges from 0-10 in 0.5 increments each representing a higher level of disability. 0 represents no disability, 1-4.5 represents people who are able to walk without an aid, 5-9.5 represents more severly disabled and impairment to walking and 10 represents death due to multiple sclerosis complications.
Participant Self-Reported MS Diagnosed Type
Self-reported by participant using pre-screening online survey.
Participant Self-Reported Most Symptomatic Functional System
Self-reported by participant using pre-screening online survey.
Participant Self-Reported Most Symptomatic Side of the Body
Self-reported by participant using pre-screening online survey.
Participant Self-Reported Dominant Side of the Body
Self-reported by participant using pre-screening online survey.
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Velocity
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Velocity
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Velocity
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Velocity
Force plate recording from single leg stance balance test.
Participant Single Leg Stance Body Sway Velocity
Force plate recording from single leg stance balance test.
Participant Sit-to-Stand Rising Index
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Rising Index
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Rising Index
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Rising Index
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Rising Index
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Weight Transfer
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Weight Transfer
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Weight Transfer
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Weight Transfer
Force plate recording from sit-to-stand test.
Participant Sit-to-Stand Weight Transfer
Force plate recording from sit-to-stand test.

Full Information

First Posted
September 5, 2021
Last Updated
October 11, 2021
Sponsor
Edinburgh Napier University
Collaborators
Scottish Hospital Endowments Research Trust, Pacla Medical Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT05090709
Brief Title
MS Spinal Mobilisation Study
Official Title
Analysis of a Spinal Mobilisation Intervention in People With Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
April 1, 2019 (Actual)
Study Completion Date
April 1, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Edinburgh Napier University
Collaborators
Scottish Hospital Endowments Research Trust, Pacla Medical Ltd

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of the study is to measure the effect of a spinal mobilisation intervention on para-spinal muscle tissue quality, functional balance measures, pain and fatigue in people with multiple sclerosis. The mobilisation intervention group will be compared to a general massage group to analyse the difference between the specificities of the intervention compared to general manual touch. Participants will be randomly allocated to a group condition for a between-subject, repeated measures study. The study hypothesises a decrease in lumbar stiffness, body sway, pain and fatigue post the intervention compared to the general massage group.
Detailed Description
The long term management of multiple sclerosis (MS) symptoms may often involve manual therapeutics due to observed improvements in muscle stiffness, pain, fatigue and balance. Though these improvements are often anecdotal without objective measurement and without analysis of the manual therapeutic. This is partly due to the vast array of manual therapeutics available as well as the many possible influencing factors contributing to these symptoms. The objective of this study is to measure and analyse the cumulative effect of a spinal mobilisation intervention on muscle tissue quality, functional balance, pain and fatigue in people with MS. The intervention will be analysed at a specific rate, pressure and location and compared to a general manual touch session with no specificities on rate, pressure or location. Both therapy sessions will be 30 minutes long. The force of both therapy sessions will be recorded in real time by monitoring the vertical ground reaction force (GRF) profile using 2 Kistler force plates placed underneath the treatment plinth. A 0 force will be generated once each participant is lying supine and still on the plinth and recordings will be taken in 30 second samples during the treatment sessions. The summation of the vertical GRFs will be graphed and monitored to check consistency of the treatment force. The mobilisation intervention will be given at a rate of 0.37Hz (22 beats per minute) maintained by a metronome on silent within view of the therapist, the pressure will be maintained at a pressure grade of less than 1 (equal to a threshold of 80N), and maintained consistent physical contact on paraspinal region within L1-L5. The general massage will be applied on the mid-lower back, with no specificities or consistencies; physical contact, rate and force magnitude will not be kept constant. This will be tested on 20 participants with MS who are randomly allocated to a group condition for a between-subject, repeated measures study. Participants will be randomly allocated to either an intervention or general massage group for which they will attend 4 separate therapy sessions. During the 1st session, the participants will carry out tests for lumbar muscle response, measured stiffness, tone and elasticity (using MyotonPro), functional balance measures in a single-leg balance and sit-to-stand tests (using Kistler force plates), self-reported pain and self-reported fatigue for pre and post treatment sessions. During the subsequent 3 sessions, the participants will complete tests for the myometer, balance and pain post the treatment sessions, and the final fatigue test will be completed after their last session. Participants will therefore complete 5 set of tests for the myometer, balance and pain and the fatigue test is completed pre and post all therapy sessions due to the set-up of the questionnaire. Participants will complete an online questionnaire before their 1st to screen for eligibility criteria and collect anthropometric details and information on their MS condition. This will be analysed with the results into descriptive statistics and summarised into mean, range and dispersion values. All dependent variables measured for muscle tissue response, functional balance, pain and fatigue will be analysed in between-subject repeated measured ANOVA to determine differences between the 2 treatment groups and between the different treatment time points. Pearson correlations will be carried out on the myometer variables to compare the baseline values to the level of change after their final session due to previously found significant correlations. More participants were intended for recruitment in the study, a post-hoc power calculation revealed a power of 0.9 with an alpha level at 0.05 with a range of large effect sizes in the results.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
multiple sclerosis, myometer, muscle stiffness, spinal mobilisations, body sway, fatigue

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Mixed factor: between-subject, repeated measures (mobilisation intervention vs general massage).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental A - Mobilisation Intervention
Arm Type
Experimental
Arm Description
Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention.
Arm Title
Experimental B - General Massage
Arm Type
Active Comparator
Arm Description
Participants receive 4 separate treatment sessions of the 30 minute general massage.
Intervention Type
Other
Intervention Name(s)
Spinal Mobilisation Intervention
Intervention Description
30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5.
Intervention Type
Other
Intervention Name(s)
General Massage
Intervention Description
30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch.
Primary Outcome Measure Information:
Title
Participant Muscle Stiffness Measure
Description
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Muscle Stiffness Measure
Description
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Muscle Stiffness Measure
Description
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Muscle Stiffness Measure
Description
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Muscle Stiffness Measure
Description
Myometer measured stiffness taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Single Leg Stance Body Sway Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Single Leg Stance Body Sway Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Single Leg Stance Body Sway Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Sit-to-Stand Velocity
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Sit-to-Stand Velocity
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Sit-to-Stand Velocity
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Sit-to-Stand Velocity
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Sit-to-Stand Velocity
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Pain Score - Visual Analogue Scale (VAS)
Description
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Pain Score - Visual Analogue Scale (VAS)
Description
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Pain Score - Visual Analogue Scale (VAS)
Description
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Pain Score - Visual Analogue Scale (VAS)
Description
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Pain Score - Visual Analogue Scale (VAS)
Description
Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.
Description
Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale.
Description
Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Secondary Outcome Measure Information:
Title
Participant Muscle Tone Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Muscle Tone Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Muscle Tone Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Muscle Tone Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Muscle Tone Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Muscle Elasticity Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Muscle Elasticity Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Muscle Elasticity Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Muscle Elasticity Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Muscle Elasticity Measure
Description
Myometer measured tone taken from Erector Spinae muscle central belly.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Height
Description
Measure taken in meters using a stadiometer.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Mass
Description
Measure taken in kilograms using digital electronic scales by the participant stepping on the scales.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant BMI
Description
Calculated using height and mass.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Age
Description
Self-reported by participant using pre-screening online survey.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Expanded Disability Status Scale (EDSS)
Description
Self-reported by participant using pre-screening online survey based on disabilities associated with multiple sclerosis. Scale ranges from 0-10 in 0.5 increments each representing a higher level of disability. 0 represents no disability, 1-4.5 represents people who are able to walk without an aid, 5-9.5 represents more severly disabled and impairment to walking and 10 represents death due to multiple sclerosis complications.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Self-Reported MS Diagnosed Type
Description
Self-reported by participant using pre-screening online survey.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Self-Reported Most Symptomatic Functional System
Description
Self-reported by participant using pre-screening online survey.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Self-Reported Most Symptomatic Side of the Body
Description
Self-reported by participant using pre-screening online survey.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Self-Reported Dominant Side of the Body
Description
Self-reported by participant using pre-screening online survey.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Anterior-Posterior Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Medial-Lateral Path Length
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Velocity
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Single Leg Stance Body Sway Velocity
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Single Leg Stance Body Sway Velocity
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Single Leg Stance Body Sway Velocity
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Single Leg Stance Body Sway Velocity
Description
Force plate recording from single leg stance balance test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Sit-to-Stand Rising Index
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Sit-to-Stand Rising Index
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Sit-to-Stand Rising Index
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Sit-to-Stand Rising Index
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Sit-to-Stand Rising Index
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.
Title
Participant Sit-to-Stand Weight Transfer
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken at baseline, pre-treatment.
Title
Participant Sit-to-Stand Weight Transfer
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 1st treatment.
Title
Participant Sit-to-Stand Weight Transfer
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 2nd treatment, 1 week after baseline.
Title
Participant Sit-to-Stand Weight Transfer
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 3rd treatment, 2 weeks after baseline.
Title
Participant Sit-to-Stand Weight Transfer
Description
Force plate recording from sit-to-stand test.
Time Frame
Taken immediately post 4th treatment, 3 weeks after baseline.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must have Multiple Sclerosis diagnosis. Must be able to walk independently. Must have an EDSS score of 6 or below. Exclusion Criteria: Respond positively to any absolute contraindications for spinal manual therapy including: segment instability infectious disease osteomyelitis bone tumours severe haemophilia spinal cord damage cervical arterial dysfunction Respond positively to any relative contraindications for spinal manual therapy including: spinal disc prolapse spondylosis inflammatory arthritides osteoporosis hypermobile syndrome pregnancy pregnancy cancer cardiovascular disease respiratory disease healing injury adverse reaction to previous spinal treatment.
Facility Information:
Facility Name
Edinburgh Napier University
City
Edinburgh
State/Province
County
ZIP/Postal Code
EH11 4BN
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymised participant data sets that underlie the results for publication will be shared on a raw data set. This includes the anthropometric data, MS information data, myometer data, functional balance data, pain and fatigue data.
IPD Sharing Time Frame
The data will be entered when the study is completed and remain until 1 year post publication of summary data.
IPD Sharing Access Criteria
the anonymised participant data underlying the summary data published will be shared on the Edinburgh Napier University University Repository with submission of PhD thesis.
IPD Sharing URL
http://researchrepository.napier.ac.uk/Output/2709099

Learn more about this trial

MS Spinal Mobilisation Study

We'll reach out to this number within 24 hrs